Objective Excessive daytime sleepiness (EDS) persists in some patients with obstructive
sleep apnea (OSA) despite continuous positive airway pressure (CPAP) treatment. This …

The COVID-19 pandemic led to significant delays in the diagnostic and management
pathway of patients with obstructive sleep apnoea (OSA). During the first wave of COVID-19 …

Background Sleep-disordered breathing (SDB) is a risk factor for recurrent adverse events in
patients with coronary artery disease (CAD). However, the prognosis of continuous positive …

Obstructive sleep apnoea (OSA) is a chronic sleep disorder characterised by recurrent
cyclical episodes of upper airway collapse causing apnoea or hypopnoea. Despite being …

Introduction: Obstructive sleep apnea (OSA) is a disorder characterized by obstructive
apneas, hypopneas, and/or arousals related to respiratory effort caused by repetitive …

Background Continuous positive airway pressure (CPAP) is the most effective treatment for
symptomatic obstructive sleep apnea (OSA). The identification of actual predictors of CPAP …

Background There is increasing prevalence of moderate to severe obstructive sleep apnea
(OSA) in adolescents, the majority of whom receive treatment with positive airway pressure …

Determining the endotypes of obstructive sleep apnea (OSA) has potential implications for
precision interventions. Here we assessed whether continuous positive airway pressure …

Background Traditionally continuous positive airways pressure (CPAP) trials for obstructive
sleep apnoea (OSA) are through face to face (F2F) set up. During Covid-19 pandemic CPAP …

Background As the prevalence of OSA increases in older patients, the proportion of elderly
patients treated with CPAP is expected to become even higher. We studied CPAP …